The Cancer Immunotherapy MSc at London Metropolitan University is designed for aspiring professionals and researchers keen to address the growing global challenge of cancer. You will explore the rapidly advancing field of immunotherapy, understanding its crucial role alongside conventional treatments like chemotherapy and radiation. This postgraduate degree provides a deep dive into cancer pharmacology and molecular oncology, equipping you with the knowledge to analyse the complex biological mechanisms driving cancer progression and the development of targeted therapies. If you are passionate about contributing to life-saving cancer research and treatment, this course offers a robust academic foundation.
You will study this programme full-time on campus over one year, engaging with modules such as Advanced Immunology, Cancer Pharmacology, and Molecular Oncology. The curriculum includes a significant Research Project, allowing you to apply your learning to current scientific questions under expert guidance. You will develop essential skills in scientific data analysis and interpretation, preparing you for advanced roles. Graduates of this MSc are well-positioned for careers in pharmaceutical research, clinical trials, oncology, and further doctoral studies, ready to make a tangible impact in the fight against cancer.